Syndax Pharmaceuticals (SNDX) PT Lowered to $28 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts SNDX Hot Sheet
Price: $10.45 --0%
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 32 | New: 6
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 32 | New: 6
Join SI Premium – FREE
Baird analyst Joel Beatty lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $28.00 (from $32.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Circle Internet Group (CRCL) PT Lowered to $100 at H.C. Wainwright
- Sky Perfect JSAT Holdings (9412:JP) PT Lowered to JPY3,319 at Nomura/Instinet
- FSN Ecommerce Ventures (NYKAA:IN) PT Raised to INR427 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
